Product Information
PYLERA 140-125-125 MG CAPSULE is a brand product labeled by H2-Pharma LLC, priced at $2.4283 per EA under NDC 61269038012. Its NADAC has been published 108 times since Jun 5, 2024.
PYLERA 140-125-125 MG CAPSULE
BISMUTH SUBCITRATE POTASSIUM, METRONIDAZOLE, and TETRACYCLINE HYDROCHLORIDEStrength
140; 125; 125 mg/1; mg/1; mg/1
Manufacturer
H2-Pharma LLCNDC
61269038012
Classification
Brand
Dosage Form
CAPSULE
Route
ORAL
Last Updated
4/22/2026
Active Ingredients
BISMUTH SUBCITRATE POTASSIUM; METRONIDAZOLE; TETRACYCLINE HYDROCHLORIDEApproval Type
New Drug (NDA)
FDA Application
NDA050786On Market Since
10/1/2023
Pharmacological Classes
Price Statistics
The NADAC for PYLERA 140-125-125 MG CAPSULE has been published 108 times since Jun 5, 2024, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $2.4283 per EA |
|---|---|
| All-time high | $2.4364 (Mar 12, 2025) |
| All-time low | $2.4257 (Aug 20, 2025) |
| 52-week high | $2.4323 |
| 52-week low | $2.4257 |
| Median price | $2.4290 |
| Average price | $2.4302 |
| Largest weekly change | -0.3% (Apr 23, 2025) |
| Weeks tracked | 108 |
| Tracking since | Jun 5, 2024 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the BISMUTH SUBCITRATE POTASSIUM, METRONIDAZOLE, and TETRACYCLINE HYDROCHLORIDE market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of PYLERA 140-125-125 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for PYLERA 140-125-125 MG CAPSULE, manufactured by H2-Pharma LLC, is $2.4283 per EA (NDC 61269038012), effective Jun 24, 2026.
How has the price of PYLERA 140-125-125 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for PYLERA 140-125-125 MG CAPSULE has held within roughly two percent of its current level. It has been tracked across 108 weekly CMS publications since Jun 5, 2024.
What are the highest and lowest recorded NADAC prices for PYLERA 140-125-125 MG CAPSULE?
Since Jun 5, 2024, the NADAC for PYLERA 140-125-125 MG CAPSULE has ranged from a low of $2.4257 (Aug 20, 2025) to a high of $2.4364 (Mar 12, 2025), with a median of $2.4290 per EA.
Are there cheaper alternatives to PYLERA 140-125-125 MG CAPSULE?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of PYLERA 140-125-125 MG CAPSULE, so no direct lower-cost alternative is listed.
Who manufactures PYLERA 140-125-125 MG CAPSULE?
PYLERA 140-125-125 MG CAPSULE (NDC 61269038012) is labeled by H2-Pharma LLC, and CMS classifies it as a brand product.
Related Drugs
Same classification